Form 8-K Arcus Biosciences, Inc. For: Oct 21
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Citi reiterates buy rating on Arcus Biosciences after stock drops 20%
October 21, 2026 4:54 PM EDTCiti analyst Yigal Nochomovitz reiterated a Buy rating and $50.00 price target on Arcus Biosciences (NYSE: RCUS) following a 20% drop in the company's share price.
According to the analyst, the stock's decline was driven in part by a follow-on offering and market expectations that the company's... More



